News

Filter by year   :   

Patents

Brazil: Endgame for Bayer’s GMO soybean patent?

A new episode in the battle over Bayer/Monsanto patents on Roundup-tolerant transgenic soybeans: on February 13, 2023, the Brazilian Supreme Court ruled in favor of the soybean producers. A hard blow for the German multinational. On February 13, 2023, Brazil’s Federal Supreme Court ordered Bayer to pay back to the soybean growers’ association Aprosoja [1] the […]

Agronomy

Risk assessment

GM soybeans: unforeseen effects

Roundup Ready soybeans benefit less from the addition of sulfur than a closely related, but not genetically modified, variety. This kind of pleiotropic effect has been observed and analyzed before. A Brazilian study (involving researchers from Embrapa, the brazilian equivalent of the French public research institute INRAE) compares the agronomic behaviour of two soybean lines […]

Lobby / conflict of interest

Is the US government cultivating a conflict of interest?

The US Department of Agriculture (USDA) has just appointed an executive of the biotechnology company Pairwise. The company will market its first genetically modified food in 2023. Evident conflict of interest or administrative routine? In November 2022, the USDA appointed Haven Baker, business manager and co-founder of Pairwise [1], to its Fruit and Vegetable Industry Advisory […]

Journal

A minority of states support deregulation of new GMOs

Many States currently reflect on the legal status of GMOs resulting from new genetic modification techniques, and some have already decided. It is not easy to give an exhaustive picture of all the positions and legislation adopted : it is sometimes difficult to have access to national legislation, national positions may be unclear at this stage, […]

Journal

Patents on life, a US ” invention ”

Historically, the protection of living organisms through patents has been developed in the United States and Europe. Abandoning a then conservative position, the US Supreme Court validated a patent on a genetically modified (GM) bacterium in 1980 [1]. This institution defined the micro-organism as a « composition of matter », opening up the field of patentability of living […]

Journal

The appropriation of living organisms: can we still control digitalization?

For the time being, digital sequence information allows certain stakeholders, including companies, to use digitalized sequences without needing the prior consent of the states and communities connected with this biodiversity. Discussions are underway in order to regulate – or not – practices which contravene the Convention on Biological Diversity. Countries allowing free access to the […]

Journal

Genetic resources : the wrong « label » ?

  What does the expression “genetic resource” really mean ? Of course, the word “genetic” is well-known and refers to the genome of living beings : their DNA or genetic “material”, but is this its present-day meaning ? And what about the addition of the word “resources” ? There is also the mention of the « digitalization of genetic resources” […]

Journal

What legislation for the digitilization of life and benefit sharing ?

  If free access to « digital sequence information » (DSI) of living organisms were to be unconditional, it would come up against the fair and equitable sharing of the benefits generated by the use of any physical genetic resource. Because this sharing of physical genetic resources is actually taking place within a framework of existing international […]

Journal

Biopiracy on digitalized sequences : two examples

If cases of biopiracy of living organisms based on digital sequence information (DSI) are not frequent for the moment, Inf’OGM is aiming to show that they are not just figments of the imagination. Without a strong reaction from the international community, the two examples presented here (the Ebola virus in West Africa and a GM […]

Filter by year   :